SuperworthGinkgo Bioworks market cap DNA
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $672.7M
- Highest close in our data
- $20B
- Nov 2021
Ginkgo Bioworks is worth $672.7M at the close on Oct 23, 2026, at $9.99 a share.
That is down 16% over the last year and down 77% over five years.
Its highest close in our data was $20B in Nov 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $672.7M | $367.2M | $875.4M | +32% |
| 2025 | $509M | $323.2M | $955.5M | −8% |
| 2024 | $555.2M | $314M | $3.2B | −84% |
| 2023 | $3.6B | $2.4B | $5.1B | +9% |
| 2022 | $3.3B | $3.2B | $10.1B | −73% |
| 2021 | $12.4B | $2.1B | $20B | n/a |
Against its peers
Companies in Biotechnology nearest Ginkgo Bioworks' size, closest first, today.
| Company | Market cap |
|---|---|
| DNAGinkgo Bioworks | $672.7M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| PLXProtalix BioTherapeutics | $205.5M |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Ginkgo Bioworks
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.